|
| Figure 2: Comparison of efficacy of different products evaluated to control WSSV infection under standardized experimental conditions. (a) Spirulina; (b) Cidofovir; (c) Hyperthermia (33˚C); (d) vp28 and vp26 dsRNA. Data from (a,b) [74]; (c) [93] and (d) [108]. |
